Anti-abortion groups plan to unveil a sprawling federal and state strategy today that would undermine the procedure’s protections enacted by ballot measure in nearly a dozen states over the past two ...
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...
Market-based solutions to hold Big Pharma accountable for their egregious anti-competitive tactics, especially patent thickets, have broad bipartisan support. Congress must pass these solutions into ...